書籍詳細

(1) 放射線治療装置と照射方法

P.5 掲載の参考文献

• 1) Washington CM,Leaver D(editors):Principles and practice of radiation therapy 2nd ed,Mosby,2004.

• 2) Khan FM:Treatment planning in radiation oncology 2nd ed,Lippincott Williams & Wilkins,2007.

• 3) Chao KSC,Apisarnthanarax S,Ozyigit G(editors):Practical essentials of intensity modulated radiation therapy 2nd ed,Lippincott Williams & Wilkins,2005.

(3) 密封小線源治療

P.14 掲載の参考文献

• 1) Devlin PM,editor:Brachytherapy:Applications and Techniques,Lippincott Williams & Wilkins,2006.

• 2) Hoskin P,Coyle C:Radiotherapy in Practice-Brachytherapy,Oxford press,2011.

(4) 定位放射線治療・強度変調放射線治療 ( IMRT )

P.23 掲載の参考文献

• 1) Leksell L:The stereotactic method and radiosurgery of the brain.Acta Chir Scand 102:316-319,1951.

• 2) Uematsu M,et al:Computed tomography guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer:a 5-years experience.Int J Radiat Onocl Biol Phys 51:666-670,2001.

• 3) Onishi H,et al:Stereotactic Hypofractionated high-dose irradiation for Stage I non small cell lung carcinoma.Cancer 101:1623-1631,2004.

• 4) Nagata Y,et al:Clinical outcomes of a phase I/II of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.Int J Radiat Oncol Biol Phys 63:1427-1431,2005.

• 5) Timmermann R,et al:Stereotactic body radiation therapy for inoperable early stage lung cancer.JAMA 303:1070-1076,2010.

• 6) Hartford AC,Palsca MG,Eicher TJ,et al:American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice guidelines for intensity-modulated radiation therapy (IMRT) .Int J Radiat Oncol Biol Phys 73:9-14,2009.

• 7) Iuchi T,et al:Hypofractioanted high-dose irradiation for the treatment of malignant astrocytoma using simultaneous integratedboost technique by IMRT.Int J Radiat Oncol Biol Phys 64:1317-1324,2006.

• 8) Lukka H,Hayter C,Julian JA,et al:Randomized trial comparing two fractionation schedules for patients with localized prostate cancer.J Clin Oncol 23:6132-6138,2005.
  pubmed

• 9) Yeoh EE,Fraser RJ,McGowen RE,et al:Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma:updated results of a phase III randomized trial.Int J Radiat Oncol Biol Phys 66:1072-1083,2006.

• 10) Pollack A,Hanlon AL,Horwitz EM,et al:Dosimetry and preliminary acute toxicity in the first 100men treated for prostate cancer on a randomized hypofractionation dose escalation trial.Int J Radiat Oncol Biol Phys 64:518-526,2006.

(5) 粒子線治療 ( 陽子線, 炭素線 )

P.33 掲載の参考文献

• 1) PTCOG:Particle Therapy Co-Operative Group,http://ptcog.web.psi.ch/

• 2) Kagawa K,Murakami M,Hishikawa Y,et al:Preclinical biological assessment of proton and carbon ion beams at hyogo ion beam medical center.Int.J.Radiation Oncology Biol Phys 54:928-938,2002.

• 3) Cozzia L,et al:A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours.Radiother Oncol 61:287-297,2001.

• 4) Hishikawa Y,Kagawa K,Murakami M,et al:Usefulness of positron-emission tomographic images after proton therapy,Int J Radiat Oncol Biol Phys 53:1388-1391,2002.
  pubmed

• 5) Shimizu M,Sasaki R,Miyawaki D,et al:Int J Radiat Oncol Biol Phys 75:580-586,2009.
  pubmed

• 6) Schulz-Ertner D and Tsujii H:Particle radiation therapy using proton and heavier ion beams.J Clin Oncol 25:953-964,2007.

• 7) Schulz-Ertner D,Nikoghosyan A,Didinger B,Munter M,Jakel O,Karger CP,Debus J:Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques.Cancer 104:338-344,2005.
  pubmed

• 8) Schulz-Ertner D,Karger CP,Feuerhake A,Nikoghosyan A,Combs SE,Jakel O,Edler L,Scholz M,Debus J:Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas.Int J Radiat Oncol Biol Phys 68:449-457,2007.
  pubmed

• 9) Nishimura H,Ogino T,Kawashima M,Nihei K,Arahira S,Onozawa M,Katsuta S,Nishio T:Proton-beam therapy for olfactory neuroblastoma.Int J Radiat Oncol Biol Phys 68:758-762,2007.
  pubmed

• 10) Yanagi T,Mizoe JE,Hasegawa A,Takagi R,Bessho H,Onda T,Kamada T,Okamoto Y,Tsujii H:Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy.Int J Radiat Oncol Biol Phys 74:15-20,2009.
  pubmed

• 11) Demizu Y,Murakami M,Miyawaki D,et al:Analysis of vision loss caused by radiation-induced optic neuropathyafter particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves.Int J Radiat Oncol Biol Phys 75:1487-1492,2009.

• 12) Miyamoto T,Baba M,Sugane T,Nakajima M,Yashiro T,Kagei K,Hirasawa N,Sugawara T,Yamamoto N,Koto M,Ezawa H,Kadono K,Tsujii H,Mizoe JE,Yoshikawa K,Kandatsu S,Fujisawa T:Working Group for Lung Cancer.Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week.J Thorac Oncol 2:916-926,2007.

• 13) Iwata H,Murakami M,Demizu Y,Miyawaki D,Terashima K,Niwa Y,Mima M,Akagi T,Hishikawa Y,Shibamoto Y:High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer.Cancer 116:2476-2485,2010.

• 14) Kato H,Tsujii H,Miyamoto T,Mizoe JE,Kamada T,Tsuji H,Yamada S,Kandatsu S,Yoshikawa K,Obata T,Ezawa H,Morita S,Tomizawa M,Morimoto N,Fujita J,Ohto M:Liver Cancer Working Group.Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis.Int J Radiat Oncol Biol Phys 59:1468-1476,2004.

• 15) Nakayama H,Sugahara S,Tokita M,Fukuda K,Mizumoto M,Abei M,Shoda J,Sakurai H,Tsuboi K,Tokuuye K:Proton beam therapy for hepatocellular carcinoma:the University of Tsukuba experience.Cancer 115 :5499-5506,2009.
  pubmed

• 16) Komatsu S,Murakami M,Fukumoto T,Hori Y,Hishikawa Y,Ku Y:Risk factors for survival and local recurrence after particle radiotherapy for single small hepatocellular carcinoma.Br J Surg 98:558-564,2011.
  pubmed

• 17) Cella L,Lomax A and Miralbell R:Potential role of intensity modulated proton beams in prostate cancer radiotherapy.Int J Radiat Oncol Biol Phys 49:217-223,2001.
  pubmed

• 18) Schneider U,Lomax A,Besserer J,et al:The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer.Int J Radiat Oncol Biol Phys 68:892-897,2007.
  pubmed

• 19) Yoon M,Ahn SH,Kim J,et al:Radiation-induced cancers from modern radiotherapy techniques:intensity-modulated radiotherapy versus proton therapy.Int J Radiat Oncol Biol Phys 77:1477-1485,2010.
  pubmed

• 20) Mayahara H,Murakami M,Kagawa K,et al:Acute morbidity of proton therapy for prostate cancer:the Hyogo Ion Beam Medical Center experience.Int J Radiat Oncol Biol Phys 69:434-443,2007.
  pubmed

• 21) Nihei K,Ogino T,Onozawa M,et al:Multi-institutional phase ii study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities.Int J Radiat Oncol Biol Phys 81:390-396,2011.
  pubmed

• 22) Slater JD,Rossi CJ Jr,Yonemoto LT,Bush DA,Jabola BR,Levy RP,Grove RI,Preston W,Slater JM:Proton therapy for prostate cancer:the initial Loma Linda University experience.Int J Radiat Oncol Biol Phys 59:348-352,2004.

• 23) Talcott JA,Rossi C,Shipley WU,et al:Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.JAMA 303(11):1046-1053,2010.
  pubmed

• 24) Ishikawa H,Tsuji H,Kamada T,Yanagi T,Mizoe JE,Kanai T,Morita S,Wakatsuki M,Shimazaki J,Tsujii H:Working Group for Genitourinary Tumors.Carbon ion radiation therapy for prostate cancer:results of a prospective phase II study.Radiother Oncol 81,57-64,2006.

• 25) DeLaney TF,Liebsch NJ,Pedlow FX,Adams J,Dean S,Yeap BY,McManus P,Rosenberg AE,Nielsen GP,Harmon DC,Spiro IJ,Raskin KA,Suit HD,Yoon SS,Hornicek FJ:Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.Int J Radiat Oncol Biol Phys 74:732-739,2009.
  pubmed

• 26) Kamada T,Tsujii H,Tsuji H,Yanagi T,Mizoe JE,Miyamoto T,Kato H,Yamada S,Morita S,Yoshikawa K,Kandatsu S,Tateishi A:Working Group for the Bone and Soft Tissue Sarcomas.Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.J Clin Oncol 20:4466-4471,2002.

• 27) Miyawaki D,Murakami M,Demizu Y,et al:Brain Injury After Proton Therapy or Carbon Ion Therapy for Head and Neck Cancers and Skull Base Tumors.Int J Radiat Oncol Biol Phys 75:378-384,2009.
  pubmed

• 28) Fukumoto T,Komatsu S,Hori Y,et al:Particle beam radiotherapy with a surgical spacer placement for advanced abdominal leiomyosarcoma results in a significant clinical benefit.Journal of Surgical Oncology 101:97-99,2010.

• 29) 河内清光:陽子線と重イオンによる治療の可能性.臨床ME 4:479-488,1980.

• 30) Saunders W,Castro JR,Chen GTY,et al:Helium-ion radiation therapy at the Lawrence Berkeley Laboratory:recent results of a Northern California Oncology Group Clinical Trial.Radiat Res Suppl 8:S227-234,1985.

• 31) Murakami M,Hishikawa Y,Miyajima S,Okazaki Y,Sutherland KL,Abe M,Bulanov SV,Daido H,Esirkepov TZ,Koga J,Yamagiwa M,Tajima T:Radiotherapy using a laser proton accelerator.Laser-Driven Relativistic Plasmas Applied for Science,Industry,and Medicine.In:Bulanov SV,Daido H eds.,AIP Conference Proceedings:pp 275-300,2008.

(6) ホウ素中性子捕捉療法

P.38 掲載の参考文献

• 1) 平塚純一:放射線治療技術の最前線「ホウ素中性子捕捉療法が拓く癌の最新治療」.新医療 33(12):74-77,2006.

• 2) 平塚純一,他:ホウ素中性子捕捉療法(BNCT)の現状と可能性-さらなる展開に向けた課題はなにか-.Digital Medicin 7(6):28-30,2009.

• 3) Miyatake S,et al:Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.J Neuro-Oncol 91(2):199-206,2009.

• 4) Yamamoto T,et al:Boron neutron capture therapy for newly diagnosed glioblastoma.Radiother Oncol 91:80-84,2009.
  pubmed

• 5) Aihara T,et al:First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET.Head and Neck 28:850-855,2006.
  pubmed

• 6) Suzuki M,et al:Impact of intra-arterial administration of boron compaunds on dose-volume histograms in boron neu-tron capture therapy for recurrent head-and-neck tumors.Int J Radiat Oncol Biol Phys 66(5):1523-1527,2006.

• 7) Hiratsuka J,et al:First clinical trial of boron neutron capture therapy for thyroid cancer Advances in Neutron Capture Therapy 2006 (edited by Nakagawa Y,Kobayashi T and Fukuda H):7-9,2006.

(7) 放射線治療における医療事故防止

P.43 掲載の参考文献

• 1) 渡辺良晴:誤照射事故から得られた教訓.日本放射線技術学会誌 62巻(5号):657-660,2006.

• 2) 保科正夫,他:放射線治療における事故事例と事故防止対策-誤照射事故の立入り調査の教訓-.放射線治療分科会誌 18巻(2号):8-13,2004.

• 3) 池田恢:放射線照射事故とその背景-現状と展望-.原子力委員会.2006年4月11日.

• 4) 医学放射線物理連絡協議会:東京都内某病院における過線量照射事故の原因及び再発防止策に関する医学放射線物理連絡協議会による調査報告書.2001年11月24日.

• 5) 医学放射線物理国連絡協議会:国立弘前病院における過剰照射事故の原因及び再発防止に関する調査報告書.2004年7月1日.

• 6) 医学放射線物理連絡協議会:山形大学病院における過小照射事故の原因及び再発防止に関する調査報告書.2004 年11月19日.

• 7) 医学放射線物理連絡協議会:和歌山県立医科大学附属病院における過剰照射事故の原因及び再発防止に関する調査報告書.2006年6月28日.

• 8) 厚生労働省医政局指導課長:診療放射線の過剰照射の防止等の徹底について.医政指発第0409001 号.2004年4月9日.

• 9) 熊谷幸三:(喚起文)放射線治療における誤照射事故防止の徹底を！.放射線治療分科会誌 18巻(2号):3-4,2004.

• 10) 放射線治療の品質管理に関する委員会:放射線治療における医療事故防止のための安全管理体制の確立に向けて(提言)最終報告.2005年9月10日.

(8) 放射線治療の副作用と対策

P.51 掲載の参考文献

• 1) Emami B,Lyman J,Brown A,et al:Tolerance of normal tissue to therapeutic irradiation.Int J Radiat Oncol Biol Phys 21:109-122,1991.
  pubmed

• 2) Inomata T,Narabayashi I,Inada Y,Shimbo T,Takahashi M,Uesugi Y,Kariya S,Nishioka A,Ogawa Y:Patients'subjective evaluation of early and late sequelae in patients with breast cancer irradiated with short fractionation for breast conservation therapy:comparison with conventional fractionation.Breast cancer 15:93-100,2008.
  pubmed

• 3) Rosen GD,Dube DS:Radiation-induced pulmonary disease,Encyclopedia of Respiratory Medicine.pp601-609,2006.

• 4) Shimbo T,Inomata T,Takahashi M,Tatsumi T,Uesugi Y,Narabayashi I,Sonobe H:Effects of sivelestat sodium hydrate on the reduction of radiation pneumonitis.International Journal of Molecular Medicine 20:817-822,2007.
  pubmed

• 5) Darby SC,McGale P,Taylor CW,et al:Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer:Prospective study of about 300,000 women in US SEER cancer registries.Lancet Oncology 6:557-565,2005.
  pubmed

• 6) Hall,EJ:Radiobiology for the radiologist 6th ed,Lippincott Williams & Wilkins,2005.

• 7) Fajardo FF,Berthrong M,Anderson RE:Radiation Pathology,Oxford University Press,2001.

• 8) Dorr W,Engenhart-Cabilic R,Zimmermann JS:Normal tissue reactions in radiotherapy and oncology.Karger,2002.

(9) 脳・脊髄腫瘍の放射線治療

P.59 掲載の参考文献

• 1) van den Bent MJ,Afra D,de Witte O,et al:Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults:the EORTC 22845 randomized trial.Lancet 366:985-990,2005.
  pubmed

• 2) Karim ABMF,Afra D,Cornu P,et al:Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult:European Organization for Research and Treatment of Cancer 22845 with the Medical Research Council study BR04:an interim analysis.Int J Radiat Oncol Biol Phys 52:316-324,2002.

• 3) Stupp R,Mason WP,van den Bent MJ,et al:Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N Engl J Med 352:987-996,2005.
  pubmed

• 4) Mizoe JE,Tsuji H,Hasegawa A,et al:Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas:combined X-ray radiotherapy,chemotherapy,and carbon ion radiotherapy.Int J Radiat Oncol Biol Phys 69:390-396,2007.
  pubmed

• 5) Mizumoto M,Tsuboi K,Igaki H,et al:Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.Int J Radiat Oncol Biol Phys 77:98-105,2010.
  pubmed

• 6) Kawabata S,Miyatake S,kuroiwa T,et al:Boron neutron capture therapy for newly diagnosed glioblastoma.J Radiat Res(Tokyo)50:51-60,2009.
  pubmed

• 7) Rodriguez D,Cheung MC,Housri N,et al:Outcomes of malignant CNS Ependymomas:An examination of 2408 cases through the surveillance,epidemiology,and end results(SEED)database(1973-2005).J Surg Res 156:340-351,2009.

• 8) Morita A,Coffey RJ, Foote RL,et al:Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas:Experience in 88 patients.J Neurosurg 90:42-49,1999.
  pubmed

(10) 頭頸部 ( 眼窩・顔面を含む ) 腫瘍の放射線治療

P.70 掲載の参考文献

• 1) 井上武宏:VII.喉頭癌,日本放射線科専門医会・医会他編:放射線治療計画ガイドライン2008.メディカル教育研究社,pp100-105,2008.

• 2) 茶谷正史:喉頭.大西洋,他編:がん・放射線療法2010.篠原出版新社,706-714,2010.

• 3) Yamazaki H,et al:Radiotherapy for early glottic carcinoma(T1N0M0):Results of prospective randomized study of radiation fraction size and over all treatment time.Int J Radiat Oncol Biol Phys 64:77-82,2006.

• 4) Inoue T,et al:Irradiated volume and arytenoid edema after radiotherapy for T1 glottic carcinoma.Strahlenther Onkol 168:23-26,1992.
  pubmed

• 5) Wang DC,et al:Longterm sulrvival of 1035 cases of nasopharyngeal carcinoma,cancer 61:2328-2341,1988.

• 6) 大西洋:IV.上咽頭癌.日本放射線科専門医会・医会他編:放射線治療計画ガイドライン2008.メディカル教育研究社,pp80-87,2008.

• 7) Cooper JS,et al:A comparison of staging systems for nasopharyngeal carcinoma.Cancer 83:213-219,1998.
  pubmed

• 8) 福原昇,他:V.中咽頭癌.日本放射線科専門医会・医会他編:放射線治療計画ガイドライン2008.メディカル教育研究社,pp88-93,2008.

• 9) 西岡健:VI.下咽頭癌.日本放射線科専門医会・医会他編:放射線治療計画ガイドライン2008.メディカル教育研究社,pp94-99,2008.

• 10) 柴山千秋,他:II.上顎癌.日本放射線科専門医会・医会他編:放射線治療計画ガイドライン2008.メディカル教育研究社,pp70-73,2008.

• 11) Nibu K,et al:Results of multimodality therapy for squamous cell carcinoma of maxillary sinus.Cancer 94:1476-1482,2002.
  pubmed

• 12) Yoshimura R,et al:Trimodal combination therapy for maxillary sinus carcinoma.Int J Radiat Oncol Biol Phys 53:656-663,2002.
  pubmed

• 13) Shibuya H,et al:Brachytherapy for stage I & II oral tongue cancer:an analysis of past cases focusing on control and complications.Int J Radiat Oncol Biol Phys 26:51-58,1993.

• 14) 西尾正道,他:舌癌頸部リンパ節転移の問題.頭頸部腫瘍24:304-310,1998.

• 15) Paterson R,et al:Interstitial treatment.In Radium Dosage:The Manchester system,Meredith WJ ed,2nd edition.Edinbergh and London,E & S Livingstone LTD,pp31-41,1967.

• 16) Inoue T,et al:Phase III trial of high-vs.low-dose-rate interstitial radiotherapy for early mobile tongue cancer.Int.J Radiat Oncol Biol Phys 51:171-175,2001.
  pubmed

• 17) 西尾正道:X.舌癌.日本放射線科専門医会・医会他編:放射線治療計画ガイドライン2008.メディカル教育研究社,pp114-118,2008.

• 18) Chao KS,et al:Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT.Int J Radiat Oncol Biol Phys 53:1174-1184,2002.
  pubmed

• 19) 不破信和:III.口腔癌(口腔底,頬粘膜,歯肉・歯槽,硬口蓋の癌).日本放射線科専門医会・医会他編:放射線治療計画ガイドライン2008.メディカル教育研究社,pp74-79,2008.

• 20) Marcus RB Jr,et al:A preloaded,custom-designedimplantation device for stage T1-T2 carcinoma of the floor of mouth.Int J Radiat Oncol Biol Phys 6:111-123,1980.
  pubmed

• 21) Urist MM,et al:Squamous cell carcinoma of buccal mucosa;Analysis of prognostic factors.Am J Surg 154:411-414,1987.
  pubmed

(11) 肺癌の放射線治療

P.79 掲載の参考文献

• 1) Pignon JP,et al:A meta-analysis of thoracic radiotherapy for small-cell lung cancer.N Engl J Med 327:1618-1624,1992.
  pubmed

• 2) Warde P & Payne D:Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis.J Clin Oncol 10:890-895,1992.
  pubmed

• 3) Fried DB,et al:Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.J Clin Oncol 22:4837-4845,2004.
  pubmed

• 4) Auperin A,et al:Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.Prophylactic Cranial Irradiation Overview Collaborative Group.N Engl J Med 341:476-484,1999.

• 5) Slotman B,et al:Prophylactic cranial irradiation in extensive small-cell lung cancer.N Engl J Med 357:664-672,2007.
  pubmed

• 6) Non-small Cell Lung Cancer Collaborative Group:Chemotherapy in non-small cell lung cancer:a meta-analysis using updated data on individual patients from 52 randomised clinical trials.BMJ 311:899-909,1995.

• 7) Auperin A,et al:Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer.J Clin Oncol 28:2181-2190,2010.
  pubmed

• 8) Yamamoto N,et al:Phase III study comparing second-and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer:West Japan Thoracic Oncology Group WJTOG0105.J Clin Oncol 28:3739-3745,2010.
  pubmed

• 9) Turrisi AT 3rd,et al:Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide.N Engl J Med 340:265-271,1999.
  pubmed

• 10) Le Pechoux C,et al:Standard-dose versus higher-dose prophylactic cranial irradiation(PCI)in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy(PCI 99-01,EORTC 22003-08004,RTOG 0212,and IFCT 99-01):a randomised clinical trial.Lancet Oncol 10:467-474,2009.
  pubmed

• 11) Marks LB,et al:Radiation dose-volume effects in the lung.Int J Radiat Oncol Biol Phys 76:S70-76,2010.
  pubmed

(12) 縦隔腫瘍の放射線治療

P.84 掲載の参考文献

• 1) Okumura M,et al:The World Health Organization histologic classification system reflects the oncologic behavior of thymoma:a clinical study of 273 patients.Cancer 94:624-632,2002.
  pubmed

• 2) Haniuda M,et al:Adjuvant radiotherapy after complete resection of thymoma.Ann Thorac Surg 54:311-315,1992.
  pubmed

• 3) Curran WJ,Jr.Kornstein MJ,Brooks JJ & Turrisi AT:3rd.Invasive thymoma:the role of mediastinal irradiation following complete or incomplete surgical resection.J Clin Oncol 6:1722-1727,1988.
  pubmed

• 4) Kondo,K. & Monden,Y:Therapy for thymic epithelial tumors:a clinical study of 1,320 patients from Japan.Ann Thorac Surg 76:878-884,discussion 884-875,2003.

• 5) Bokemeyer C,et al:Extragonadal germ cell tumors of the mediastinum and retroperitoneum:results from an international analysis.J Clin Oncol 20:1864-1873,2002.
  pubmed

• 6) Bokemeyer C,et al:Extragonadal seminoma:an international multicenter analysis of prognostic factors and long term treatment outcome.Cancer 91:1394-1401,2001.
  pubmed

• 7) Uematsu M,et al:The role of radiotherapy in the treatment of primary mediastinal seminoma.Radiother Oncol 24:226-230,1992.
  pubmed

(13) 乳癌・乳腺腫瘍の放射線治療 ( 乳房温存療法を含む )

P.96 掲載の参考文献

• 1) がん・放射線療法2010.篠原出版新社,東京,2010.

• 2) 日本乳癌学会編:科学的根拠に基づく乳癌診療ガイドライン 3.放射線療法2008年版.2008.

• 3) 日本放射線科専門医会・医会,日本放射線腫瘍学会,日本医学放射線学会編:2008 放射線治療計画ガイドライン.2008.

• 4) 笹岡政宏:乳癌 Field-in-field radiotherapy.JASTRO Newsletter 98:20-24,2010.

• 5) 光森通英:放射線療法.乳癌の臨床 特別号 2010:46-52,2010.

• 6) Ogo E,et al:Int J Radiat Oncol Biol Phys 71:123-131,2008.
  pubmed

• 7) Ogawa Y,et al:Int J Oncol 34:609-618,2009.
  pubmed

• 8) Kariya S,et al:Int J Radiat Oncol Biol Phys 75:449-454,2009.
  pubmed

• 9) Ogawa Y,et al:Int J Oncol 39:553-560,2011.
  pubmed

(14) 消化器癌の放射線治療

P.103 掲載の参考文献

• 1) Minsky BD,et al:INT 0123 (Radiation TherapyOncology Group 94-05) phase III trial of combined-modality therapy for esophagealcancer:high-dose versus standard-dose radiation therapy.J ClinOncol 20 :1167-1174,2002.

• 2) Burmeister BH,et al:Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus:a randomised controlled phase III trial.Lancet Oncol 6:659-668,2005.
  pubmed

• 3) Kato H,et al:Liver Cancer Working Group.Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis.Int J Radiat Oncol Biol Phys 59:1468-1476,2004.

• 4) Zeng ZC,et al:A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferiorvena cava tumor thrombus.Int J RadiatOncolBiolPhys 61:432-443,2005.

• 5) Nishimura Y,et al:External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer:analysis of survival rates and complications.Int J Radiat Oncol Biol Phys 39:39-49,1997.
  pubmed

• 6) Sebag-Montefiore D,et al:Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer(MRC CR07 and NCIC-CTG C016):a multicentre,randomised trial.Lancet 373(9666):790-792,2009.

• 7) Collette L,et al:European Organisation for Research and Treatment of Cancer Radiation Oncology Group.Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy:does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.J Clin Oncol 25(28):4379-4386,2007.
  pubmed

• 8) Sauer R,et al:German Rectal Cancer Study Group.Preoperative versus postoperative chemoradiotherapy for rectal cancer.N Engl J Med 351:1731-1740,2004.

• 9) Kapiteijn E,et al:Dutch Colorectal Cancer Group.Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.N Engl J Med 345(9):638-646,2001.
  pubmed

• 10) Nagtegaal ID,et al:What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26(2):303-312,2008.
  pubmed

(15) 女性生殖器腫瘍の放射線治療

P.115 掲載の参考文献

• 1) http//www.nccn.org/professionals/physician_gls/PDF/cervical.pdf

• 2) Landoni F,Maneo A,Colombo A,et al:Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer.Lancet 350:535-540,1997.
  pubmed

• 3) 日本婦人科腫瘍学会編:子宮頸癌ガイドライン2007 年版.金原出版,2007.

• 4) 日本婦人科腫瘍学会編:子宮頸癌ガイドライン2011 年版.金原出版,2011.

• 5) Morris M,et al:Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.N Engl J Med 340:1137-1143,1999.
  pubmed

• 6) Keys HM,et al:Cisplatin,radiation,and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.N Engl J Med 340:1154-1161,1999.
  pubmed

• 7) Whitney CW,et al:Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes:a Gynecologic Oncology Group and Southwest Oncology Group study.J Clin Oncol 17:1339-1348,1999.

• 8) Rose PG,et al:Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.N Engl J Med 340:1144-1153,1999.
  pubmed

• 9) Pearcey R,et al:Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.J Clin Oncol 20:966-972.2002.
  pubmed

• 10) Thomas G,et al:A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer.Gynecol Oncol 69:137-145,1998.
  pubmed

• 11) Wong LC,et al:Chemoradiation and adjuvant chemotherapy in cervical cancer.J Clin Oncol 17:2055-2060,1999.
  pubmed

• 12) Robert KB et al:Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix.Int J Cancer 90:206-223,2000.

• 13) Green JA,et al:Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix:a systematic review and meta-analysis.Lancet 358:781-786,2001.
  pubmed

• 14) Toita T,et al:Radiotherapy for uterine cervical cancer:results of the 1995-1997 patterns of care process survey in Japan.Jpn J Clin Oncol 35:139-148,2005.
  pubmed

• 15) Monk BJ,et al:Phase III trial of four cisplatin-containing double combination in stage IVb,recurrent,or persistent cervical carcinoma:A Gynecologic Oncology Group Study.J Clin Oncol 27:4649-4655,2009.

• 16) Chatani M,et al:High-dose rate intracavitary irradiation for carcinoma of the uterine cervix.The adverse effect of treatment prolongation.Strahlenther Onkol 173:379-384,1997.
  pubmed

• 17) Nag S,et al:The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.Int J Radiat Oncol Biol Phys 48:201-211,2000.
  pubmed

• 18) Announcements,FIGO stages-1988 revision.Gynecol Oncol 35:125-127,1989.

• 19) 婦人科腫瘍委員会報告:2007年度子宮体癌患者年報.日産婦会誌 61:935-963,2009.

• 20) Creutzberg CL,et al:POTEC Study group,Survival after relapse in patients with endometrial cancer:results from a randomized trial.Gynecol Oncol 89:201-209,2003.

• 21) Keys HM,et al:A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma:a Gynecologic Oncology Group study.Gynecol Oncol 92:744-751,2004.

• 22) Sagae S,et al:JGOG2033.Randomized phase III trial of whole pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate risk endometrial carcinoma.ASCO 23:455(#5002),2005.

• 23) 婦人科腫瘍委員会第35回治療年報.日産婦会誌 50:278-305,1998.

• 24) NCI Common Terminology Criteria for Adverse Events v3.0(CTCAE)(http//ctep.cancer.gov/forms/CTCAEv3.pdf)

• 25) Perez CA,Gersell DJ,McGuire WP,et al:Vagina.In:Hoskins WJ,Perez CA,Young RC,eds:Principles and practice of gynecologic oncology 3rd ed.:Philadelphia,Lippincott Williams & Wilkins,pp811-840,2000.

• 26) Ansink A,et al:Surgical interventions for early squamous cell carcinoma of the vulva(Cochrane Review).The Cochrane Library,Issue 4,Oxford:Update Software Ltd,2002.

• 27) Montana GS,et al:Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes:a Gynecologic Oncology Group study.Int J Radiat Oncol Biol Phys 48:1007-1013,2000.

• 28) Cunningham MJ,et al:Primary radiation,cisplatin,and 5-fluorouracil for advanced squamous carcinoma of the vulva.Gynecol Oncol 66:258-261,1997.
  pubmed

• 29) Frank SJ,et al:Definitive radiation therapy for squamous cell carcinoma of the vagina.Int J Radiat Oncol Biol Phys 62:138-147,2005.
  pubmed

• 30) Burke TW,et al:Vulva.In:Hoskins WJ,et al(eds):Principles and practice of gynecologic oncology 3rd ed.Philadelphia,Lippincott Williams & Wilkins,pp775-810,2000,

• 31) Homesley HD,et al:Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes.Obstet Gynecol 68:733-740,1986.
  pubmed

• 32) Russell AH:Vulva.In:Leibel SA,et al(eds):Textbook of radiation oncology.Philadelphia,Saunders, pp907-925,1998.

(16) 泌尿生殖器腫瘍の放射線治療

P.123 掲載の参考文献

• 1) Ajay N,Debra J,Michaela M,Steven JJ,Michael L,JL St.Sauver:Prostate and urinary incontinence.The Journal of Urology 181(4)Supplement 1:591,2009.

• 2) Horie S,Tobisu K,Fujimoto H,Doi N,Kakizoe T:Urinary incontinence after non-nerve-sparing radical prostatectomy with neoadjuvant androgen deprivation.Urology 53(3):561-567,1999.
  pubmed

• 3) Michael JZ,Deborah AK,Larry BL,Louis P,David CB,John CB,Brian JM,Jay PC,Anthony LZ,Thomas MP,Mohamed E,Eric MH:Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.International Journal of Radiation Oncology Biology Physics 67(2):327-333,2007.

• 4) Cox JD,Ang KK,editors:Radiation oncology 9th ed:28.prostate,Mosby Elsevier,pp 676-732,2010.

• 5) Halperin EC,Perez CA,Brady LW,editors:Principles and practice of radiation oncology 5th ed:Chapter 62 Low-risk prostate cancer and Chapter 63 Intermediate-and High-risk prostate cancer Lippincott Williams & Wilkins,pp 1439-1502,2008.

• 6) Hoppr RT,Phillips TL,Roach M,editors:Textbook of radiation oncology 3rd ed:Chapter 45 Cancer of the prostate,Saunders Elsevier,pp925-986,2010.

• 7) Donald SK,Kathryn AW,William US, Niall MH,H James W III,Leonard MT,Anthony LZ,Simon T,Howard MS:Phase I-II RTOG Study(99-06)of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery,Paclitaxel,Cisplatin,and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy.Urology 73(4):833-837,2009.
  pubmed

• 8) Tamim MN,Luis S,Khalil S,Marie D,George S,Carolyn F:Long-term results of para-aortic irradiation for patients with Stage I seminoma of the testis.International Journal of Radiation Oncology Biology Physics 61(3):741-744,2005.

(17) 悪性リンパ腫の放射線治療

P.129 掲載の参考文献

• 1) Maeda LS,Advani RH:The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma.Curr Opin Oncol 21:397-400,2009.
  pubmed

• 2) Henry-Amar M,Somers R:Survival outcome after Hodgkin's disease.Sem Oncol 17:758,1990.

• 3) Bonnet F,Fillet G,Mounier N,et al:CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphomas de'Adulte.J Clin onol 25:787-792,2007.

• 4) Reyes F,Lepage E,Ganem G,et al:ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.N Eng J Med 352:1197-1205,2005.

(18) 血液腫瘍の放射線治療

P.134 掲載の参考文献

• 1) Druker BJ,et al:Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.N Engl J Med 355:2408-2417,2006.
  pubmed

• 2) 上紺屋憲彦,他:放射線照射時の口腔粘膜障害予防と亜鉛.治療別冊87:36-40,2005.

• 3) 上紺屋憲彦,他:小児におけるTBI-BMT 治療の晩発性障害-TBI-BMTと成長障害について.日本放射線腫瘍学会誌 11:263-269,1999.

• 4) Witherspoon RP,et al:Secondary cancers after bonemarrow transplantation for leukemia or aplastic anemia.N Engl J Med 321:784-789,1989.
  pubmed

(19) 皮膚・軟部・骨腫瘍の放射線治療

P.138 掲載の参考文献

• 1) Sasaki R,Soejima T,Sugimura K,et al:Angiosarcoma treated with radiotherapy:impact of tumor type and size on outcome.Int J Radiat Oncol Biol Phys 52(4):1032-1040,2002.
  pubmed

• 2) Nagano T,Yamada Y,Ikeda T,et al:Docetaxel:a therapentic option in the treatment of cutaneous angiosarcoma:report of a patients.Cancer 110(3):648-651,2007.

• 3) Yang JC,Chang AE,Rosenberg SA,et al:Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.J Clin Oncol 16(1):197-203,1998.
  pubmed

(20) 小児腫瘍の放射線治療

P.145 掲載の参考文献

• 1) http://www.nch.go.jp/policy/shoumann16/shoumann16.htm.

• 2) 副島俊典:小児腫瘍:総論.大西洋編:がん放射線治療2010.篠原出版社,pp1118-1120,2010.

• 3) Reulen RC,et al:Long-term risks of subsequent primary neoplasms among survivors of childhood cancer.JAMA 305:2311-2319,2011.
  pubmed

• 4) Cohn SL,et al:The International Neuroblastoma Risk Group (INRG) classification system:an INRG Task Force report.J Clin Oncol 27:289-297,2009.
  pubmed

• 5) Haas-Kogan DA,et al:Impact of radiotherapy for high-risk neuroblastoma:a Children's Cancer Group study.Int J Radiat Oncol Biol Phys 56:28-39,2003.

• 6) Kalapurakal JA:Wilms'tumor.Principles and practice of radiation oncology.5th edition,pp1850-1857,2008.

• 7) Kalapurakal JA,et al:Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms'tumor treated on NWTS-3 and NWTS-4:a report from the National Wilms' Tumor Study Group.Int J Radiat Oncol Biol Phys 57:495-499,2003.

• 8) Haas-Kogan DA,Diana F,Wharam MD:Soft tissue sarcoma.Leibel and Phillips Textbook of Radiation Oncology,2010.

• 9) Breneman JC,et al:Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyo-sarcoma-a report from the Intergroup Rhabdomyosarcoma Study IV.J Clin Oncol 21:78-84,2003.

• 10) Hosoi H,et al:A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan.Int J Clin Oncol 12:137-145,2007.
  pubmed

(21) 良性疾患の放射線治療

P.149 掲載の参考文献

• 1) Leer JW,van Houtte P,Davelaar J:Indications and treatment schedules for irradiation of benign diseases:a survey.Radiother Oncol 48:249-257,1998.

• 2) Leer JW,van Houtte P,Seegenschmiedt H:Radiotherapy of non-malignant disorders:where do we stand? Radiother Oncol 83:175-177,2007.
  pubmed

• 3) Kal HB,Veen RE,Jurgenliemk-Schulz IM:Dose-effect relationships for recurrence of keloid and pterygium after surgery and radiotherapy.Int J Radiat Oncol Biol Phys 74:245-251,2009.
  pubmed

• 4) Ogawa R,Yoshitatsu S,Yoshida K,Miyashita T:Is radiation therapy for keloids acceptable? The risk of radiation-induced carcinogenesis.Plast Reconstr Surg 124:1196-1201,2009.
  pubmed

• 5) Gerling J,et al:Retrobulbar irradiation for thyroid-associated orbitopathy:double-blind comparison between 2.4 and 16 Gy.Int J Radiat Oncol Biol Phys 55:182-189,2003.
  pubmed

• 6) Marquez SD,et al:Long-term results of irradiation for patients with progressive Graves'ophthalmopathy.Int J Radiat Oncol Biol Phys 51:766-774,2001.
  pubmed

• 7) Tsujino K,et al:Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy.Int J Radiat Oncol Biol Phys 48:857-864,2000.

• 8) Maruyama K,et al:The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations.N Engl J Med 352:146-153,2005.
  pubmed

(22) 緩和療法としての放射線治療

P.155 掲載の参考文献

• 1) Janjan NA,Delcos ME,Ballo MT,et al:Palliative care.In:Cos JD eds.Radiation Oncology 8th ed.St Louis,Mosby,954-986,2003.

• 2) Body JJ:Metastatic bone disease;clinical and therapeutic aspects.Bone 13(suppl 1):s57-62,1992.

• 3) Loblaw DA,Laperriere NJ:Emergency treatment of malignant extradural spinal cord compression:an evidence-based guideline.J Clin Oncol 16:1613-1614,1998.
  pubmed

• 4) Gasper L,Scott C,Rotman M,et al:Recursive partitioning analysis(RPA)of prognostic factor in three Radiation Therapy Oncology Group(RTOG)brain metastases trials.Int J Radiat Oncol Biol Phys 37:745-751,1997.

• 5) Patchell RA,Tibbs PA,Regine WF,et al:Postoperative radiotherapy in the treatment of single metastases to the brain:a randomized trial.JAMA 280:1485-1489,1998.

(23) 放射線治療と化学療法 ( 分子標的剤を含む )

P.162 掲載の参考文献

• 1) Steel GG,Pechham MJ:Exploitable mechanisms in combined radiotherapy-chemotherapy:The concept of additivity.Int J Radiat Oncol Biol Phys 5:85-91,1979.

• 2) Pignon JP,le Maitre A,Maillard E,et al:Meta-analysis of chemotherapy in head and neck cancer(MACH-NC):An update on 93 randomized trials and 17364 patients.Radiother Oncol 92:4-14,2009.

• 3) Vermorken JB,Remenar E,van Herpen C,et al:Cisplatin,fluorouracil,and docetaxel in unresectable head and neck cancer.N Engl J Med 357:1695-1704,2007.
  pubmed

• 4) BonnerJA,HarariPM,GiraltJ,et al:Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck.N Engl J Med 354:567-578,2006.
  pubmed

• 5) Pfister DG,Su YB,Kraus DH,et al:Concurrent Cetuximab,Cisplatin,and Concomitant Boost Radiotherapy for Locoregionally Advanced,Squamous Cell Head and Neck Cancer:A Pilot Phase II Study of a New Combined-Modality Paradigm.J Clin Oncol 24:1072-1078,2006.
  pubmed

• 6) De Ruysscher D,Pijls-Johannesma M,Vansteenkiste J,et al:Systematic review and meta-analysis of randomised,controlled trials of the timing of chest radiotherapy in patients with limited-stage,small-cell lung cancer.Ann Oncol 17:543-552,2006.
  pubmed

• 7) Crino L,Weder W,van Meerbeeck J,Felip E:On behalf of the ESMO Guidelines Working Group.Early stage and locally advanced(non-metastatic)non-small-cell lung cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up.Ann Oncol 21(Supplement 5):103-115,2010.

• 8) Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration(CCCMAC):Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer:individual patient data meta-analysis(Review).The Cochrane Library,2010,Issue 1,Wiley.

• 9) Stupp R,Mason WP,van den Bent MJ,et al:Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N Engl J Med 352:987-996,2005.
  pubmed